Company Name : Bhc Lab Private Ltd.
Address : Unit II, 91/2, D.I.C., Baddi, Distt. Solan (H.P.)
Tel No: 01795-650644
Website : http://bhclab.co.in/
Company Profile
BHC Lab .came into existence in the year 1996 in the manufacturing of Ayurvedic Medicines. In 2005, the company expanded its scope to the field of allopathy by starting a tablet and capsule (Non Betalactum) division. With over 100 employees at present, we are catering to various companies which include Ind Swift, Galpha Laboratories, Bio Chem, Elder Pharmaceuticals, VHB Lifesciences, MacRemedies, Medley Pharmaceuticals, Marksana Pharma, Khandelwal Laboratories, Dr. Morpen , Nicholas Piramal and Intas Pharmaceutical.
The company has been allotted manufacturing license and GMP for the biological & non Biological products by HP State Drug Controller, to manufacture formulations of Tablets and Capsules. The Company has a defined Self Inspection System through which all manufacturing functions, Engineering Department, Quality Control Department and warehouse are audited by a team of Managers consisting of Works Manager, Q.A. Manager and Production Manager and the Department Head of Department being audited. The audit is carried out as per the SOP. All deficiencies noted in the inspection are attended to by the Departmental Head and a report issued by him.
In the year 2009, we started with our two marketing divisions in the name of Wallaby (Ethical Division) and Saraah Biotech (Branded Generics Division) and since then, we have made all India monopoly distributors for these two divisions.
Pearson Syndrome is an extremely rare condition and the prevalence is approximately 1 in a…
A striking 90% of the 3000 Diabetologists and Endocrinologists surveyed, emphasised the importance of continuous…
People who smoke are also at much higher risk of developing diabetes compared to non-smokers…
17th edition of CPHI& PMEC India Expo to be held from 26th November-28thNovember 2024, at the India…
Lonavala, November 12, 2024: As the global cancer burden rises to 30 million cases by…
The launch signifies Equitas’ redefined commitment to bring world-class cancer radiation therapy accessible to all.…